Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 248

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 248
---

ticket sales, registration income, locker income and income other than general operations. During the years ended March 31, 2025 and
2024, other income mainly consisted of anniversary ticket sales of $414,935 and nil, respectively.

The Company is not subject to tax on income
or capital gains under the current laws of the Cayman Islands and British Virgin Islands.

The Company’s subsidiary in Hong Kong
is subject to the income tax of Hong Kong. No taxable income was generated outside Hong Kong for the years ended March 31, 2025 and 2024.
The Company accounts for income taxes in accordance with ASC 740, “Income Taxes”. ASC 740 requires an asset and liability
approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based
upon the likelihood of realization of tax benefits in future. Under the asset and liability approach, deferred taxes are provided for
the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes
and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not
that they will either expire before the Company is able to realize the benefits, or future deductibility is uncertain.

<div align='center'>F-13</div>

ASC 740-10-25 prescribes a more-likely-than-not
threshold for financial statement recognition and measurement of a tax position taken (or expected to be taken) in a tax return. It also
provides guidance on the recognition of income tax assets and liabilities, classification accounting for interest and penalties associated
with tax positions, years open for tax examination, accounting for income taxes in interim periods and income tax disclosures. There
were no material uncertain tax positions as of March 31, 2025 and 2024.

The Company identifies related parties, accounts
for, and discloses related party transactions in accordance with ASC 850, “Related Party Disclosures” and other relevant
ASC standards.

The Company presents comprehensive income
in accordance with ASC Topic 220, Comprehensive Income, (“ASC 220”). ASC 220 states that all items that are required to be
recognized under accounting standards as components of comprehensive income be reported in the consolidated financial statements. Total
comprehensive income consists of two components, net income and other comprehensive income. Other comprehensive income refers to revenue,
expenses, gains and losses that are recorded as an element of shareholders’ equity but are excluded from net income. Other